Metabolische Chirurgie und Remission des Diabetes mellitus Typ 2

Zusammenfassung

Aus der zunächst zur Gewichtsreduktion entstandenen bariatrischen Chirurgie entwickelt sich derzeit die metabolische Chirurgie. Bei Patienten mit Typ-2-Diabetes scheinen die Eingriffe am Magen-Darm-Trakt nicht nur eine effektive Methode zur Gewichtsreduktion zu sein, sondern auch das Potential zu besitzen, das mit der Adipositas einhergehende metabolische Syndrom chirurgisch zu verbessern. Auch wenn genaue Indikationen noch anhand prospektiv randomisierter Studien evaluiert werden müssen, scheint ein chirurgischer Therapie-Ansatz des Diabetes mellitus Typ 2 möglich. Diese Arbeit gibt einen Überblick über die derzeit etablierten chirurgischen Verfahren in der bariatrischen Chirurgie und zeigt mögliche Perspektiven für eine chirurgische Therapie des Diabetes mellitus Typ 2 auf.

Abstract

A new therapeutic field is developing from bariatric surgery. Gastrointestinal surgery does not only seem to be a very efficacious method for weight reduction but may also have the potential to reduce obesity-related metabolic disorders. Even if there is still a lack of prospective randomized trials evaluating the correct indications for metabolic surgery in patients with type 2 diabetes mellitus, there is the legitimate expectation that the surgical approach can be successful. This article provides anan overview of the current state of bariatric surgery and gives a surgical perspective on the treatment of type 2 diabetes mellitus.

Schlüsselwörter

Diabetes mellitus Typ 2 - bariatrische Chirurgie - metabolische Chirurgie

Keywords

type 2 diabetes mellitus - bariatric surgery - metabolic surgery

Literatur

• 1 Adams T D, Gress R E, Smith S C. et al . Long-term mortality after gastric bypass surgery.  N Engl J Med. 2007;  357 753-761
• 2 Arner P, Pollare T, Lithell H. Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects.  Diabetologia. 1991;  34 483-487
• 3 Arterburn D E, Crane P K, Veenstra D L. The efficacy and safety of sibutramine for weight loss: a systematic review.  Arch Intern Med. 2004;  164 994-1003
• 4 Astrup A, Madsbad S, Breum L. et al . Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial.  Lancet. 2008;  372 1906-1913
• 5 Baltasar A, Serra C, Perez N. et al . Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation.  Obes Surg. 2005;  15 1124-1128
• 6 Bolinder J, Lithell H, Skarfors E. et al . Effects of obesity, hyperinsulinemia, and glucose intolerance on insulin action in adipose tissue of sixty-year-old men.  Diabetes. 1986;  35 282-290
• 7 Buse J B, Rosenstock J, Sesti G. et al . Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).  Lancet. 2009;  374 39-47
• 8 Castaneda C, Layne J E, Munoz-Orians L. et al . A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes.  Diabetes Care. 2002;  25 2335-2341
• 9 Christensen R, Kristensen P K, Bartels E M. et al . A meta-analysis of the efficacy and safety of the anti-obesity agent Rimonabant.  Ugeskr Laeger. 2007;  169 4360-4363
• 10 Church T S, Earnest C P, Skinner J S. et al . Effects of different doses of physical activity on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial.  JAMA. 2007;  297 2081-2091
• 11 Cohen R V, Schiavon C A, Pinheiro J S. et al . Duodenal-jejunal bypass for the treatment of type 2 diabetes in patients with body mass index of 22 – 34 kg/m²: a report of 2 cases.  Surg Obes Relat Dis. 2007;  3 195-197
• 12 Dansinger M L, Gleason J A, Griffith J L. et al . Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial.  JAMA. 2005;  293 43-53
• 13 DePaula A L, Macedo A L, Mota B R. et al . Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21 – 29.  Surg Endosc. 2009;  23 1313-1320
• 14 DePaula A L, Macedo A L, Rassi N. et al . Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35.  Surg Endosc. 2008;  22 706-716
• 15 DePaula A L, Macedo A L, Rassi N. et al . Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.  Surg Endosc. 2008;  22 2670-2678
• 16 DePaula A L, Macedo A L, Schraibman V. et al . Hormonal evaluation following laparoscopic treatment of type 2 diabetes mellitus patients with BMI 20 – 34.  Surg Endosc. 2009;  23 1724-1732
• 17 Elton C W, Tapscott E B, Pories W J. et al . Effect of moderate obesity on glucose transport in human muscle.  Horm Metab Res. 1994;  26 181-183
• 18 Flum D R, Belle S H, King W C. et al . Perioperative safety in the longitudinal assessment of bariatric surgery.  N Engl J Med. 2009;  361 445-454
• 19 Foster G D, Wyatt H R, Hill J O. et al . A randomized trial of a low-carbohydrate diet for obesity.  N Engl J Med. 2003;  348 2082-2090
• 20 Gantz I, Erondu N, Mallick M. et al . Efficacy and safety of intranasal peptide YY3 – 36 for weight reduction in obese adults.  J Clin Endocrinol Metab. 2007;  92 1754-1757
• 21 Greve J W, Rubino F. Bariatric surgery for metabolic disorders.  Br J Surg. 2008;  95 1313-1314
• 22 Guidone C, Manco M, Valera-Mora E. et al . Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery.  Diabetes. 2006;  55 2025-2031
• 23 Kelley D E, Bray G A, Pi-Sunyer F X. et al . Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial.  Diabetes Care. 2002;  25 1033-1041
• 24 MacLean L D, Rhode B M, Nohr C W. Late outcome of isolated gastric bypass.  Ann Surg. 2000;  231 524-528
• 25 Maggard M A, Shugarman L R, Suttorp M. et al . Meta-analysis: surgical treatment of obesity.  Ann Intern Med. 2005;  142 547-559
• 26 Marceau P, Hould F S, Simard S. et al . Biliopancreatic diversion with duodenal switch.  World J Surg. 1998;  22 947-954
• 27 Mingrone G, Rosa G, Di Rocco P. et al . Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement.  Int J Obes Relat Metab Disord. 2002;  26 1165-1172
• 28 Muscelli E, Mari A, Casolaro A. et al . Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients.  Diabetes. 2008;  57 1340-1348
• 29 Noya G, Cossu M L, Coppola M. et al . Biliopancreatic diversion preserving the stomach and pylorus in the treatment of hypercholesterolemia and diabetes type II: results in the first 10 cases.  Obes Surg. 1998;  8 67-72
• 30 O’Brien P Em Dixon JB. Lap-band: outcomes and results.  J Laparoendosc Adv Surg Tech A. 2003;  13 265-270
• 31 Oh I S, Shimizu H, Satoh T. et al . Identification of nesfatin-1 as a satiety molecule in the hypothalamus.  Nature. 2006;  443 709-712
• 32 Padwal R, Li S K, Lau D C. Long-term pharmacotherapy for obesity and overweight.  Cochrane Database Syst Rev. 2003;  4, CD004094.
• 33 Pories W J, Swanson M S, MacDonald K G. et al . Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus.  Ann Surg. 1995;  222 339-350; discussion 350 – 352
• 34 Rubino F, Forgione A, Cummings D E. et al . The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes.  Ann Surg. 2006;  244 741-749
• 35 Scopinaro N, Adami G F, Marinari G M. et al . Biliopancreatic diversion.  World J Surg. 1998;  22 936-946
• 36 Sjostrom L, Narbro K, Sjostrom C D. et al . Effects of bariatric surgery on mortality in Swedish obese subjects.  N Engl J Med. 2007;  357 741-752
• 37 Sloth B, Davidsen L, Holst J J. et al . Effect of subcutaneous injections of PYY1 – 36 and PYY3 – 36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males.  Am J Physiol Endocrinol Metab. 2007;  293 E604-609
• 38 Stern L, Iqbal N, Seshadri P. et al . The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial.  Ann Intern Med. 2004;  140 778-785
• 39 Sundbom M, Karlson B M. Low Mortality in Bariatric Surgery 1995 Through 2005 in Sweden, in Spite of a Shift to More Complex Procedures.  Obes Surg. 2008;  19 1697-1701
• 40 Suter M, Jayet C, Jayet A. Vertical banded gastroplasty: long-term results comparing three different techniques.  Obes Surg. 2000;  10 41-46; discussion 47
• 41 Torgerson J S, Hauptman J, Boldrin M N. et al . XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.  Diabetes Care. 2004;  27 155-161
• 42 Vettor R, Serra R, Fabris R. et al . Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies.  Diabetes Care. 2005;  28 942-949
• 43 Weeke P, Andersson C, Fosbol E L. et al . The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus – an analysis from the SCOUT lead-in period.  BMC Endocr Disord. 2010;  10 3
• 44 Wirth A. Therapieverfahren bei Adipositas.  Dtsch Med Wochenschr. 2009;  134 1074-1076
• 45 Wirth A, Krause J. Long-term weight loss with sibutramine: a randomized controlled trial.  JAMA. 2001;  286 1331-1339
• 46 Wittgrove A C, Clark G W. Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3 – 60 month follow-up.  Obes Surg. 2000;  10 233-239
• 47 WHO Website: http://www.who.int/mediacenter/factsheets/fs311/en/index.html/
• 48 Leitlinien DAG: www.adipositas-gesellschaft.de/leitlinien.php